Please select your view
Assoc. Prof. Hemmings worked in Auckland, Christchurch and Canberra and undertook sabbatical fellowships in London and Boston. Dr Hemmings has subspecialty expertise in soft tissue, gastrointestinal, and head, neck and endocrine pathology and she has a particular interest in rare cancers including sarcoma, neuroendocrine tumours and GIST, and in tumour biology as it informs the multidisciplinary management of cancer. She belongs to several professional interest groups in these areas, including COSA, AGITG, ASSG, ENETS, ANZNET and the European Society of Pathology. Dr Hemmings serves on the ASSG Scientific Advisory Committee, the WA Colorectal Tumour Collaborative Group and the Clinical Advisory Group of the National Bowel Cancer Screening Programme, and she is a founding member and foundation Secretary/Treasurer of the Australasian Gastrointestinal Pathology Society.
Dr Travis Brown obtained his MBBS from the Australian National University (ANU) in Canberra. After completing two years as a junior doctor at St Vincent Hospital in Melbourne, he undertook Anatomical Pathology training at Ballarat Base Hospital and the Royal Melbourne Hospital before transferring to General Pathology Specialty training with Healthscope Pathology (now Australian Clinical Labs) in Clayton, Melbourne. Before studying medicine, Travis completed a Bachelor of Commerce/Bachelor of Computing at the University of Ballarat and worked for two years in the Global Risk Management Services (Information Technology) department with PricewaterhouseCoopers in Melbourne.
He also completed a Bachelor of Science (Medical Sciences) at La Trobe University in Melbourne before entering graduate entry medicine at Canberra. Travis completed General Pathology Specialty training in November 2016 and is currently working in Wayville, Adelaide with Australian Clinical Labs. He enjoys the diversity that General Pathology provides working in biochemistry, microbiology, haematology and anatomical pathology. Travis also has a special interest in Information Technology and Pathology informatics.
Dr Mirette Saad is a Chemical Pathologist and the National Clinical Director of the Molecular Genetic Pathology at Australian Clinical Labs.
Dr Saad’s current professional interests are continuing development in Molecular Genetics and Chemistry. In addition to her daily work to provide a comprehensive Chemical Pathology testing service, she currently medically supervises the Molecular Genetic testing for non-invasive prenatal testing (NIPT), hereditary disorders, personalised drug therapy and cancer. She is working closely with Health Practitioners and the laboratory team to employ the knowledge and identify opportunities to provide the best diagnostic services which include interpretation of results and the provision of important consultative advice to doctors in assisting with the management plans of patients.
Professor O’Toole is recognised as one of Australia’s leading molecular pathologists, with major research and diagnostic interests in breast cancer as well as the molecular pathology of melanoma and lung cancer. She was an expert member of the working group for Cancer Australia on Influencing Best Practice in Breast Cancer and is a National Breast Cancer Foundation Practitioner Fellow.
Professor O’Toole is Clinical Professor at Sydney Medical School and head of Breast Cancer Translational Research at the Garvan Institute of Medical Research where she collaborates with researchers and clinicians nationally and internationally to promote the rapid translation of scientific discoveries. Her work has appeared in more than 100 scientific publications and she has secured over $20 million in research funding as a chief investigator. She is Chair of Cancer Services for the Royal College of Pathologists of Australasia.
Her areas of interest include Molecular Pathology, Breast Pathology and GIT/Hepatobiliary Pathology. She is FRCPA and holds MB, BS (Hons I and the University Medal), BSc Med (Hons I and recipient of the Prize for Experimental Pathology) and a PhD.
Dr Tan joined St John of God Pathology in November 2012. She graduated with first class honours degrees in both Medical Science and Medicine from the University of Tasmania. After completing her internship and residency at Royal Perth Hospital, she commenced her Anatomical Pathology Fellowship training in Sydney where she completed rotations at Royal North Shore Hospital, Westmead Hospital and Liverpool Hospital.
Dr Tan has special interests in gynaecological and placental pathology and cytopathology, in particular Fine Needle Aspiration biopsies.
In 2015, Dr Tan joined the St John of God Cancer Research Group and helped establish the Gynaecological Cancer Research Group. Her research team is working on a number of translational projects in gynaecologic oncology and has established a research database incorporating the Western Australian Gynaecological Oncology (WAGO) biobank. The main focus of her current research is clinicopathologic aspects of uterine and ovarian cancers. She has a clinical appointment (Senior Lecturer) with the School of Surgery at the University of Western Australia.
Dr Tan is a member of the gynaecology, cytopathology and HNE subspecialty teams.
New analyser provides faster turnaround times for Hepatitis B, Hepatitis C and HIV molecular testing
Clinical Labs welcomes reversal of cuts to the Bulk Bill Incentive
Australian Clinical Labs establishes National Centre of Excellence for Tuberculosis Testing in Geelong
Clinical Labs has invested in cutting edge technology with the acquisition of the Roche Cobas c513 Analyser